Temple spinout obtains exclusive license for CRISPR gene-editing tool – Philadelphia Business Journal
Philadelphia Business Journal |
Temple spinout obtains exclusive license for CRISPR gene-editing tool
Philadelphia Business Journal Philadelphia-based Excision BioTherapeutics said Monday it has become the first company to secure an exclusive license from the University of California-Berkeley for its new discovery related to the CRISPR-Cas gene-editing technology. CRISPR is an … The quest to make CRISPR gene editing as easy as a smartphone app Genome Editing Market Is Projected To Attain Value Of $8.1 Billion By 2025: Grand View Research, Inc. |
